
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $30B | $31.8B | $34.4B | $37.1B | $38.2B | |
Revenue Growth (YoY) | -6.59% | 6.02% | 8.14% | 8.01% | 3.01% | |
Cost of Revenues | $21.8B | $24.2B | $25.9B | $27.4B | $27.9B | |
Gross Profit | $8.2B | $7.6B | $8.5B | $9.8B | $10.3B | |
Gross Profit Margin | 27.27% | 24% | 24.77% | 26.33% | 26.93% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | $6.3B | $6.2B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $6.3B | $5.9B | $5.9B | $6.4B | $6.1B | |
Operating Income | $1.8B | $1.7B | $2.6B | $3.4B | $4.2B | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $2.3B | $2.4B | $2.8B | $4.1B | $4.8B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $675.8M | $663.8M | $790.6M | $1.2B | $1.3B | |
Net Income to Company | $2.3B | $2.4B | $2.8B | $4.1B | $4.8B | |
Minority Interest in Earnings | -$217M | -$351.1M | -$393.8M | -$708.9M | -$746.3M | |
Net Income to Common Excl Extra Items | $1.4B | $1.4B | $1.6B | $2.2B | $2.7B | |
Basic EPS (Cont. Ops) | $2.85 | $2.94 | $3.37 | $4.54 | $5.66 | |
Diluted EPS (Cont. Ops) | $2.85 | $2.94 | $3.37 | $4.54 | $5.66 | |
Weighted Average Basic Share | $485.4M | $485.6M | $485.7M | $483.6M | $482.3M | |
Weighted Average Diluted Share | $485.5M | $485.6M | $485.7M | $483.6M | $482.3M | |
EBITDA | $3.6B | $3.9B | $4.2B | $5.8B | $6.7B | |
EBIT | $2.3B | $2.5B | $2.9B | $4.2B | $5.1B | |
Revenue (Reported) | $30B | $31.8B | $34.4B | $37.1B | $38.2B | |
Operating Income (Reported) | $1.8B | $1.7B | $2.6B | $3.4B | $4.2B | |
Operating Income (Adjusted) | $2.3B | $2.5B | $2.9B | $4.2B | $5.1B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $8.7B | $7.9B | $8.5B | $8.7B | $9.4B | |
Revenue Growth (YoY) | 8.26% | -8.59% | 7% | 3.16% | 6.32% | |
Cost of Revenues | $6.4B | $6B | $6.4B | $6.4B | $6.9B | |
Gross Profit | $2.2B | $1.9B | $2.1B | $2.4B | $2.4B | |
Gross Profit Margin | 25.82% | 23.89% | 24.6% | 27.06% | 25.95% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | $1.5B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $1.6B | $1.5B | $1.4B | $1.6B | $1.5B | |
Operating Income | $611.6M | $418.3M | $728M | $734.9M | $949.1M | |
Net Interest Expenses | -- | -- | -- | $210.3M | -- | |
EBT. Incl. Unusual Items | $858.6M | $491M | $756.4M | $494.8M | $1.1B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $190.9M | $125.1M | $141.2M | $126.5M | $329.5M | |
Net Income to Company | $870.9M | $445.8M | $728.3M | $451.5M | -- | |
Minority Interest in Earnings | -$103.6M | -$55.7M | -$130.8M | -$50M | -$177.3M | |
Net Income to Common Excl Extra Items | $564.2M | $310.2M | $484.4M | $318.3M | $617.9M | |
Basic EPS (Cont. Ops) | $1.16 | $0.64 | $1.00 | $0.66 | $1.28 | |
Diluted EPS (Cont. Ops) | $1.16 | $0.64 | $1.00 | $0.66 | $1.28 | |
Weighted Average Basic Share | $485.4M | $485.6M | $485.7M | $482.5M | $482.3M | |
Weighted Average Diluted Share | $485.5M | $485.6M | $486.7M | $482.5M | $482.4M | |
EBITDA | $1.2B | $854.4M | $1.1B | $677.6M | $1.6B | |
EBIT | $868.9M | $502M | $771.5M | $476.9M | $1.1B | |
Revenue (Reported) | $8.7B | $7.9B | $8.5B | $8.7B | $9.4B | |
Operating Income (Reported) | $611.6M | $418.3M | $728M | $734.9M | $949.1M | |
Operating Income (Adjusted) | $868.9M | $502M | $771.5M | $476.9M | $1.1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $30B | $31.7B | $34.3B | $37.2B | $38.7B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $21.9B | $24.1B | $25.8B | $27.4B | $28.3B | |
Gross Profit | $8.2B | $7.6B | $8.5B | $9.8B | $10.4B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | $6.3B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $6.3B | $5.9B | $5.9B | $6.6B | $6.2B | |
Operating Income | $1.8B | $1.7B | $2.6B | $3.2B | $4.3B | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $2.3B | $2.5B | $2.8B | $3.4B | $4.9B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $678.7M | $659.9M | $791M | $1B | $1.3B | |
Net Income to Company | $2.3B | $2.4B | $2.8B | $3.4B | -- | |
Minority Interest in Earnings | -$218.9M | -$353.9M | -$390.9M | -$528.7M | -$754.7M | |
Net Income to Common Excl Extra Items | $1.4B | $1.4B | $1.6B | $1.9B | $2.8B | |
Basic EPS (Cont. Ops) | $2.86 | $2.96 | $3.36 | $3.84 | $5.74 | |
Diluted EPS (Cont. Ops) | $2.86 | $2.96 | $3.36 | $3.84 | $5.74 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $3.6B | $3.9B | $4.2B | $4.8B | $6.8B | |
EBIT | $2.3B | $2.5B | $2.9B | $3.5B | $5.1B | |
Revenue (Reported) | $30B | $31.7B | $34.3B | $37.2B | $38.7B | |
Operating Income (Reported) | $1.8B | $1.7B | $2.6B | $3.2B | $4.3B | |
Operating Income (Adjusted) | $2.3B | $2.5B | $2.9B | $3.5B | $5.1B |
Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
---|---|---|---|---|---|---|
Revenue | $23.2B | $25B | $26.9B | $18.7B | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $17.5B | $18.9B | $19.8B | $13.7B | -- | |
Gross Profit | $5.6B | $6.2B | $7B | $5B | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | $3.1B | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $4.3B | $4.2B | $4.6B | $3B | -- | |
Operating Income | $1.3B | $2B | $2.4B | $2B | -- | |
Net Interest Expenses | -- | -- | $210.3M | -- | -- | |
EBT. Incl. Unusual Items | $1.9B | $2.2B | $2.5B | $2.3B | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $405.6M | $554M | $740.3M | $634.6M | -- | |
Net Income to Company | $1.9B | $2.1B | $2.4B | -- | -- | |
Minority Interest in Earnings | -$289.6M | -$293.5M | -$399.8M | -$355.2M | -- | |
Net Income to Common Excl Extra Items | $1.2B | $1.3B | $1.4B | $1.4B | -- | |
Basic EPS (Cont. Ops) | $2.53 | $2.77 | $2.87 | $2.80 | -- | |
Diluted EPS (Cont. Ops) | $2.53 | $2.77 | $2.87 | $2.80 | -- | |
Weighted Average Basic Share | $1.5B | $1.5B | $1.5B | $964.6M | -- | |
Weighted Average Diluted Share | $1.5B | $1.5B | $1.5B | $964.7M | -- | |
EBITDA | $2.9B | $3.2B | $3.6B | $3.2B | -- | |
EBIT | $2B | $2.2B | $2.6B | $2.4B | -- | |
Revenue (Reported) | $23.2B | $25B | $26.9B | $18.7B | -- | |
Operating Income (Reported) | $1.3B | $2B | $2.4B | $2B | -- | |
Operating Income (Adjusted) | $2B | $2.2B | $2.6B | $2.4B | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $9.3B | $7.9B | $6.5B | $5.6B | $5.6B | |
Short Term Investments | $1.8B | $1B | $1B | $1.5B | $2.2B | |
Accounts Receivable, Net | $4.1B | $3.6B | $3.9B | $3.9B | $3.9B | |
Inventory | $3.2B | $3B | $3.5B | $3.8B | $3.8B | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $1.2B | $1.3B | $1.1B | $1.1B | $1.2B | |
Total Current Assets | $19.6B | $16.8B | $16.1B | $15.8B | $16.9B | |
Property Plant And Equipment | $8.9B | $8.5B | $10.3B | $10.6B | $11.5B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $419.4M | $469.7M | $297M | $268.4M | $264.2M | |
Total Assets | $36.6B | $34B | $36.5B | $38B | $40.1B | |
Accounts Payable | $3B | $2.4B | $2.9B | $2.9B | $2.8B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $2.5B | $2.4B | $3.6B | $3.6B | $3.8B | |
Total Current Liabilities | $15.3B | $10.3B | $11.4B | $11.8B | $10.7B | |
Long-Term Debt | $1.8B | $4B | $3.1B | $2.2B | $2.9B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $18.2B | $15.5B | $15.9B | $15.7B | $15.4B | |
Common Stock | $1.3B | $1.1B | $1B | $914.2M | $924.7M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $15.3B | $15.4B | $17.2B | $18B | $19.9B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $3.1B | $3.2B | $3.4B | $4.4B | $4.8B | |
Total Equity | $18.4B | $18.5B | $20.6B | $22.4B | $24.6B | |
Total Liabilities and Equity | $36.6B | $34B | $36.5B | $38B | $40.1B | |
Cash and Short Terms | $11.1B | $8.9B | $7.6B | $7B | $7.8B | |
Total Debt | $7B | $5.5B | $5.7B | $5.2B | $4.8B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $9.3B | $7.9B | $6.5B | $5.6B | $5.6B | |
Short Term Investments | $1.8B | $1B | $1B | $1.5B | $2.2B | |
Accounts Receivable, Net | $4.1B | $3.6B | $3.9B | $3.9B | $3.9B | |
Inventory | $3.2B | $3B | $3.5B | $3.8B | $3.8B | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $1.2B | $1.3B | $1.1B | $1.1B | $1.2B | |
Total Current Assets | $19.6B | $16.8B | $16.1B | $15.8B | $16.9B | |
Property Plant And Equipment | $8.9B | $8.5B | $10.3B | $10.6B | $11.5B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $419.4M | $469.7M | $297M | $268.4M | $264.2M | |
Total Assets | $36.6B | $34B | $36.5B | $38B | $40.1B | |
Accounts Payable | $3B | $2.4B | $2.9B | $2.9B | $2.8B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $2.5B | $2.4B | $3.6B | $3.6B | $3.8B | |
Total Current Liabilities | $15.3B | $10.3B | $11.4B | $11.8B | $10.7B | |
Long-Term Debt | $1.8B | $4B | $3.1B | $2.2B | $2.9B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $18.2B | $15.5B | $15.9B | $15.7B | $15.4B | |
Common Stock | $1.3B | $1.1B | $1B | $914.2M | $924.7M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $3.1B | $3.2B | $3.4B | $4.4B | $4.8B | |
Total Equity | $18.4B | $18.5B | $20.6B | $22.4B | $24.6B | |
Total Liabilities and Equity | $36.6B | $34B | $36.5B | $38B | $40.1B | |
Cash and Short Terms | $11.1B | $8.9B | $7.6B | $7B | $7.8B | |
Total Debt | $7B | $5.5B | $5.7B | $5.2B | $4.8B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $2.3B | $2.4B | $2.8B | $4.1B | $4.8B | |
Depreciation & Amoritzation | $1.3B | $1.4B | $1.3B | $1.6B | $1.6B | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$52.3M | $595.9M | -$397.1M | -$289.2M | -$58M | |
Change in Inventories | $208.9M | $84.8M | -$849.8M | -$321.2M | -$106.4M | |
Cash From Operations | $3.9B | $2B | $2.1B | $3.5B | $4.4B | |
Capital Expenditures | $1.6B | $1.7B | $1.9B | $2.5B | $2.6B | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$2.2B | -$1.4B | -$2.2B | -$3.3B | -$3.1B | |
Dividends Paid (Ex Special Dividend) | -$389.2M | -$423.9M | -$345.3M | -$352.2M | -$465.5M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $2.7B | $3.4B | $814.7M | $1.4B | $1.9B | |
Long-Term Debt Repaid | -$756.2M | -$2.5B | -$681.4M | -$1.2B | -$2B | |
Repurchase of Common Stock | -- | -- | -$7.4K | -$138.6M | -$6.6K | |
Other Financing Activities | -$27.6M | -$26.7K | -$99.5M | -$7.2M | -$80.7M | |
Cash From Financing | $2.9B | -$1.4B | $233.8M | -$643.8M | -$1.2B | |
Beginning Cash (CF) | $4B | $8.2B | $6.4B | $6B | $5.5B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $4.6B | -$773.9M | $114.9M | -$474.8M | $53.8M | |
Ending Cash (CF) | $8.7B | $7.6B | $6.5B | $5.8B | $5.5B | |
Levered Free Cash Flow | $2.3B | $274.2M | $209.9M | $1B | $1.8B |
Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $472.2M | $647.9M | $572M | $699.9M | $1.7B | |
Depreciation & Amoritzation | $417.7M | $361.4M | $506.7M | $416M | $627.2M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$559.3M | -$457.4M | -$245.6M | -$319.8M | -$370.8M | |
Change in Inventories | -$170M | $185M | -$135.7M | -$240.8M | $307.7M | |
Cash From Operations | -$65.6M | $1.3B | $339.9M | $1.2B | $2.2B | |
Capital Expenditures | $506.2M | $405.6M | $538.7M | $574.6M | $678.1M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$1B | -$848.5M | -$321.3M | -$1.1B | -$1.1B | |
Dividends Paid (Ex Special Dividend) | -$103.6K | $5.9M | -$5.2M | -$14.5M | -$7.9M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $159.3M | $137.3M | $695.5M | $194.3M | $154M | |
Long-Term Debt Repaid | -$231.1M | -$257.8M | -$907.8M | -$133.8M | -$115.9M | |
Repurchase of Common Stock | -- | -- | -- | -$310 | -$3.2M | |
Other Financing Activities | $349.6K | $568K | $8.5K | -$90.9M | -$7.2M | |
Cash From Financing | $268.3M | -$249M | -$558.2M | -$783.8K | -$96.4M | |
Beginning Cash (CF) | $4.8B | $8.4B | $7.9B | $6.2B | $4.7B | |
Foreign Exchange Rate Adjustment | -$89.9M | $121.2M | $165.3M | $31.2M | $137.5M | |
Additions / Reductions | -$816.1M | $239.9M | -$539.6M | $34.1M | $972.9M | |
Ending Cash (CF) | $3.9B | $8.7B | $7.6B | $6.5B | $5.8B | |
Levered Free Cash Flow | -$571.8M | $931.8M | -$198.8M | $584.3M | $1.1B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $2.1B | $2.5B | $2.7B | $3.1B | -- | |
Depreciation & Amoritzation | $1.3B | $1.3B | $1.4B | $1.4B | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$154.2M | $384M | -$322.9M | -$238.2M | -- | |
Change in Inventories | -$146M | $405.5M | -$744.8M | -$869.6M | -- | |
Cash From Operations | $2.5B | $3B | $1.3B | $2.5B | -- | |
Capital Expenditures | $1.7B | $1.6B | $1.9B | $2B | $1.7B | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$2.4B | -$1.9B | -$1.4B | -$3.3B | -- | |
Dividends Paid (Ex Special Dividend) | -$395.2M | -$412.8M | -$336M | -$358.8M | -$175.1M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $2.7B | $2.8B | $1.3B | $1.5B | -- | |
Long-Term Debt Repaid | -$729.5M | -$1.9B | -$1.5B | -$1.2B | -- | |
Repurchase of Common Stock | -- | -- | -- | -$135.5M | -- | |
Other Financing Activities | -$27.9M | $532.8K | -$8.7M | -$90.9M | -- | |
Cash From Financing | $3.4B | -$1.1B | -$323.7M | -$548.2M | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $3.5B | $5.6M | -$458.7M | -$1.4B | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $795.6M | $1.4B | -$573.2M | $456.2M | -- |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.